TRPC6 enhances angiotensin II-induced albuminuria.
暂无分享,去创建一个
E. Finch | R. Gbadegesin | L. Barisoni | P. Rosenberg | M. Sparks | G. Hall | P. Lavin | Guanghong Wu | Alison Homstad | M. Winn | Jarrett L. Burch | Jason Eckel | Brandy L. Bowling | N. Mukerji | Alison Byrd | Zhu Shan Zhang | L. Birbaumer
[1] E. Finch,et al. TRPC6 enhances angiotensin II-induced albuminuria (Journal of the American Society of Nephrology (2011) 22 (526-535)) , 2013 .
[2] T. Meyer,et al. Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice. , 2010, American journal of physiology. Renal physiology.
[3] N. Chen,et al. Identification and functional analysis of a novel TRPC6 mutation associated with late onset familial focal segmental glomerulosclerosis in Chinese patients. , 2009, Mutation research.
[4] H. Rockman,et al. A role for the thromboxane receptor in L-NAME hypertension. , 2008, American journal of physiology. Renal physiology.
[5] R. Gbadegesin,et al. Therapeutic targets in focal and segmental glomerulosclerosis , 2008, Current opinion in nephrology and hypertension.
[6] V. D’Agati. The spectrum of focal segmental glomerulosclerosis: new insights , 2008, Current opinion in nephrology and hypertension.
[7] D. Marchuk,et al. Hypertension and albuminuria in chronic kidney disease mapped to a mouse chromosome 11 locus. , 2007, Kidney international.
[8] E. Olson,et al. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. , 2006, The Journal of clinical investigation.
[9] M. Nishida,et al. TRPC3 and TRPC6 are essential for angiotensin II‐induced cardiac hypertrophy , 2006, The EMBO journal.
[10] S. Shankland,et al. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. , 2006, Kidney international.
[11] D. Clapham,et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function , 2005, Nature Genetics.
[12] T. Gudermann,et al. Increased Vascular Smooth Muscle Contractility in TRPC6−/− Mice , 2005, Molecular and Cellular Biology.
[13] Benjamin R. Rost,et al. The diacylgylcerol-sensitive TRPC3/6/7 subfamily of cation channels: functional characterization and physiological relevance , 2005, Pflügers Archiv.
[14] M. Pericak-Vance,et al. A Mutation in the TRPC6 Cation Channel Causes Familial Focal Segmental Glomerulosclerosis , 2005, Science.
[15] Hyung-Suk Kim,et al. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. , 2005, The Journal of clinical investigation.
[16] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[17] B. Brenner,et al. Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. , 2000, Kidney international.
[18] Corinne Antignac,et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome , 2000, Nature Genetics.
[19] H. Pavenstädt,et al. Roles of the podocyte in glomerular function. , 2000, American journal of physiology. Renal physiology.
[20] P. Várnai,et al. Signaling events activated by angiotensin II receptors: what goes before and after the calcium signals. , 1998, Endocrine research.
[21] L Peltonen,et al. Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. , 1998, Molecular cell.
[22] T. Meyer,et al. Podocyte loss and progressive glomerular injury in type II diabetes. , 1997, The Journal of clinical investigation.
[23] J. Hodgin,et al. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. , 1995, Hypertension.
[24] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.
[25] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .
[26] M. Rastaldi,et al. Induction of TRPC6 channel in acquired forms of proteinuric kidney disease. , 2007, Journal of the American Society of Nephrology : JASN.
[27] T. Meyer,et al. Impact of genetic background on nephropathy in diabetic mice. , 2006, American journal of physiology. Renal physiology.
[28] J. Gloy,et al. Angiotensin II increases the intracellular calcium activity in podocytes of the intact glomerulus. , 2000, Kidney international.
[29] A Fournier,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.